T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Steven Madden
SHOO
$3.46B
| $105M | 0.01% |
2,258,703
-684,162
| -23% | -$31.5M |
|
752
Glacier Bancorp
GBCI
$6.48B
| $105M | 0.01% |
1,847,650
-27,736
| -1% | -$1.57M |
|
753
IQVIA
IQV
$39.8B
| $105M | 0.01% |
371,184
-12,111
| -3% | -$3.14M |
|
754
Churchill Downs
CHDN
$6.2B
| $105M | 0.01% |
869,432
-107,004
| -11% | -$12.7M |
|
755
Trane Technologies
TT
$105B
| $104M | 0.01% |
513,739
-11,727
| -2% | -$2.21M |
|
756
Primerica
PRI
$9.62B
| $103M | 0.01% |
673,850
-33,927
| -5% | -$5.38M |
|
757
Seer Inc
SEER
$116M
| $103M | 0.01% |
4,512,861
-1,042,161
| -19% | -$30M |
|
758
Zegna
ZGN
$3.73B
| $102M | 0.01% |
+10,278,100
| New | +$117M |
|
759
Essent Group
ESNT
$6.23B
| $102M | 0.01% |
2,249,724
-69,846
| -3% | -$3.2M |
|
|
ATRI
760
DELISTED
Atrion Corp
ATRI
| $102M | 0.01% |
145,019
-2,688
| -2% | -$1.93M |
|
761
Simply Good Foods
SMPL
$989M
| $102M | 0.01% |
2,457,521
+311,681
| +15% | +$11.9M |
|
|
NARI
762
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $102M | 0.01% |
1,119,275
+241,112
| +27% | +$20.7M |
|
763
Kraft Heinz
KHC
$30.1B
| $102M | 0.01% |
2,844,059
-1,830,225
| -39% | -$65.8M |
|
764
Zurn Elkay Water Solutions
ZWS
$8.41B
| $102M | 0.01% |
2,804,062
-2,765,099
| -50% | -$99.5M |
|
765
Omnicell
OMCL
$1.72B
| $101M | 0.01% |
559,513
-46,000
| -8% | -$7.98M |
|
766
Nucor
NUE
$61.8B
| $101M | 0.01% |
882,608
-30,900
| -3% | -$3.38M |
|
767
Autodesk
ADSK
$54.5B
| $101M | 0.01% |
357,685
-16,414
| -4% | -$4.78M |
|
|
FBMS
768
DELISTED
The First Bancshares, Inc.
FBMS
| $100M | 0.01% |
2,599,143
-105,119
| -4% | -$4.19M |
|
|
IBTX
769
DELISTED
Independent Bank Group, Inc.
IBTX
| $100M | 0.01% |
1,389,282
+181,255
| +15% | +$13.1M |
|
770
Brady Corp
BRC
$4.43B
| $100M | 0.01% |
1,856,489
-243,582
| -12% | -$12.8M |
|
771
Gentherm
THRM
$1.32B
| $99.7M | 0.01% |
1,147,582
-297,774
| -21% | -$25.1M |
|
772
Federal Signal
FSS
$7.51B
| $99.7M | 0.01% |
2,300,085
-14,849
| -0.6% | -$645K |
|
773
Dorman Products
DORM
$3.95B
| $99.5M | 0.01% |
880,537
-16,010
| -2% | -$1.74M |
|
774
KT
KT
$9.03B
| $99M | 0.01% |
7,876,195
| – | – |
|
775
Timken Company
TKR
$9.1B
| $98.7M | 0.01% |
1,424,923
-3,432
| -0.2% | -$241K |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.